Skip to content
Wearables & measurementResearch article4 min read

Apple Watch rhythm tracking worked for dementia caregivers, less so for people with dementia

MoveVitals Editorial Collective · Study published · Reading updated

Original paper:Enhancing a Behavioral Intervention Using Rest-Activity Rhythm Monitoring via a Consumer Wearable in Older Dementia Caregivers and People With Dementia: Feasibility and Acceptability Study. · JMIR formative research · 2026 · Original paper ↗

Key takeaway

In a single-arm pilot of 21 older adults (15 dementia caregivers, 6 people with dementia), everyone wore an Apple Watch long enough to chart a rest-activity rhythm, and all 15 caregivers still used the app at week 6. With no control group and only 11 caregivers completing mood and sleep measures, the symptom improvements cannot be credited to the monitoring.

Study design

Research article

Reading basis

Published abstract

Reading focus

Design & applicability

The research question

Disrupted daily rest-activity rhythms are linked to poorer brain and mental health in later life, yet clinicians rarely monitor them. The authors tested whether a 6-week behavioral therapy could be personalized with rhythm data from a consumer smartwatch, and whether caregivers and people with dementia would use and accept it.

Who and how

Single-arm feasibility and acceptability trial of a behavioral activation rhythm treatment supported by the Apple Watch app myRhythmWatch, which showed participants and therapists their rest-activity patterns to set targets and track progress. Participants were 15 dementia caregivers (mean age 61.8, SD 8.4 years) and 6 people with dementia (mean age 81.45, SD 8.5 years). Feasibility was the share with at least 3 consecutive valid days of 20 or more hours each, plus total valid days; acceptability was rated on a Likert scale. In 11 caregivers, changes in depression (9-item Patient Health Questionnaire) and insomnia (Insomnia Severity Index) were examined before and after.

What it found

The authors’ reported results. Read each estimate with its population and uncertainty.

  1. 1
    All 21 participants met the minimum data requirement to characterize a rest-activity rhythm snapshot.
  2. 2
    Caregivers averaged 35 valid monitoring days and all 15 were still using the app at week 6; people with dementia averaged 30 valid days, and the authors report lower use rates in this group.
  3. 3
    Caregivers completed an average of 5.7 (SD 0.46) of the 6 therapy sessions offered, and satisfaction with program components was rated high.
  4. 4
    Among the 11 caregivers with questionnaire data, depression symptoms improved (t(10) = 2.417; P = .02; Hedges g 0.67, 95% CI 0.04-1.28), as did insomnia symptoms (t(10) = 3.377; P = .004; Hedges g 0.94, 95% CI 0.25-1.61).

Limits & uncertainty

  1. 1
    Single-arm pilot with no comparison group, so symptom changes could reflect the therapy itself, time or expectations rather than the monitoring.
  2. 2
    Small sample, with only 6 people with dementia and 11 caregivers contributing symptom scores; the confidence intervals are wide.
  3. 3
    Use among people with dementia was lower, which the authors say points to more barriers to long-term wearable monitoring in this group.
  4. 4
    Whether monitoring improves therapy efficiency, efficacy or durability was not tested; the authors call for randomized controlled trials.

What to take from it

A smartwatch can collect enough day-and-night data to give a therapist a useful picture of a caregiver's routine, and caregivers were willing to keep using it. This pilot does not show that adding monitoring makes therapy work better, and it did not test people with dementia in a way that supports routine use. Care decisions should involve the clinician.

Reading your own data

Rest-activity rhythm is the pattern of when you are active and when you rest across days. You can approximate it with regular sleep and wake times, daytime step counts and wearing the watch continuously; compare weeks using the same watch and wear habits. Consistency of routine is more informative than any one night.

How to read this evidence

The index does not establish a precise design. Read the methods before making causal claims; check population, comparator, outcomes and uncertainty in the source.

Authors’ structured abstract English

The attributed English abstract is reproduced under the recorded open licence. It is source material, not a MoveVitals interpretation. The prepared analysis above separates the authors’ findings from our interpretation.

Background

Despite being established risk factors for poor mental or brain health outcomes in aging, rest-activity rhythm (RAR) disturbances are not routinely monitored or treated. This is, in part, due to a lack of clinician-friendly RAR monitoring systems.

Objective

We tested the feasibility and acceptability of personalizing a 6-week behavioral intervention using RAR monitoring from a consumer wearable device (Apple Watch). We selected a target population study of people with dementia and their family caregivers, given that rest-activity pattern disturbances are common in these groups.

Methods

This single-arm trial enhanced a behavioral activation rhythm treatment with the Apple Watch-based app myRhythmWatch, providing users and their therapists with objective RAR monitoring for customizing therapy. Therapists used information from the myRhythmWatch app to visualize the participants' behavioral patterns, identify treatment targets, and track progress. Participants included 21 older adults (15 dementia caregivers: mean age 61.8, SD 8.4 years; 6 people with dementia: mean age 81.45, SD 8.5 years). Feasibility outcomes were as follows: (1) proportion adherent enough to assess RARs (defined as ≥3 consecutive valid days with ≥20 hours per day) and (2) the total number of valid days. Acceptability was measured via the Likert scale to gauge participants' satisfaction with the intervention. We secondarily examined preintervention and postintervention changes in depression (9-item Patient Health Questionnaire scores) and insomnia (Insomnia Severity Index) scores among a smaller group of 11 caregivers who completed these measures.

Results

All 21 participants obtained the minimum data requirement for characterizing an RAR snapshot. Caregivers averaged 35 valid RAR monitoring days, and all 15 caregivers were still using the app at week 6 of the trial. In contrast, people with dementia averaged 30 valid days, and of the 6 people with dementia, only 6 were active users at the end of the trial. On average, caregivers completed 5.7 (SD 0.46) of the 6 therapy sessions offered, and participant satisfaction with program components was "high." Depression symptoms improved with medium preintervention and postintervention effect sizes ( t _(10)=2.417; P =.02; Hedges g =0.67, 95% CI 0.04-1.28), and there were large effect size improvements in insomnia symptoms ( t _(10)=3.377; P =.004; Hedges g =0.94, 95% CI 0.25-1.61).

Conclusions

These findings show that older adults without dementia were highly engaged with RAR monitoring. This supports the feasibility of personalizing interventions for older adults with objective RAR monitoring. Randomized controlled trials are warranted to determine whether adding RAR monitoring improves intervention efficiency, efficacy, or durability. While feasible in a subset of people with dementia, we observed lower use rates indicating that there are more barriers to implementing long-term consumer wearable-based RAR monitoring in people with dementia.

Sources & attribution

Enhancing a Behavioral Intervention Using Rest-Activity Rhythm Monitoring via a Consumer Wearable in Older Dementia Caregivers and People With Dementia: Feasibility and Acceptability Study.

Stahl ST, Rodakowski J, Patira R, Smagula SF.

JMIR formative research · 2026-09-30

DOI: 10.2196/88773 ↗PubMed · 42815039 ↗Europe PMC · Recorded licence: cc by ↗

Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.

MoveVitals editorial interpretation · educational content · no individual clinical review recorded

Sources checked 2026-11-01

Practical guides

Read in context

·Cohort study

Activity–stroke and heart attack curves differ by accelerometer processing method

Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.

Preventive Medicine

In-depth explainersRead study →
·Validation study/review

Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven

A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.

Forensic Science International

In-depth explainersRead study →
·Overview of reviews

Activity trackers: about 1,800 more steps a day, but small effects on other outcomes

An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.

The Lancet Digital Health

In-depth explainersRead study →
·Validation study/review

Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages

In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.

Sleep

In-depth explainersRead study →
Wearables & measurement →